These 3 Healthcare Stocks Have Crushed the Market This Year. Here’s Why There’s More Upside Ahead
They are riding strong tailwinds that could lift them higher.
Fastly’s CEO Sold Over 18,000 Company Shares. What Does That Mean for Investors?
Fastly, which delivers edge cloud solutions for digital businesses, reported a recent insider sale after a 202% one-year share price increase.
Is Bristol Myers Squibb’s Dividend Too Good to Be True? Here’s My Honest Answer
Sometimes you need to look beyond the numbers to get the full story.
Intel Just Posted Its Fastest Revenue Growth in More Than 15 Years, but the Stock Is Falling. Here’s What’s Going On.
A 25% growth rate from a company that was barely growing a year ago. Investors took notice after hours. But then they changed their minds.
Why Booz Allen Hamilton Stock Soared Today
There’s more than one reason investors clicked the buy button on Booz Allen stock today
Alphabet: Is the Stock a Buy on the Dip as Cloud Revenue Surges?
Alphabet shares sank after its Q2 earnings report.
Navitas Semiconductor vs. ServiceNow: What Recent Quarterly Revenue Trends Tell Investors About These Tech Companies
ServiceNow’s revenue has grown steadily to $4 billion, while Navitas has contracted sharply — but its recent uptick hints at a potential inflection point.
Elon Musk’s SpaceX Flies 20 Starlink V3 Satellites Tonight. The Stock Sits 49% Below Its High.
Tonight’s launch window opens at 6:45 p.m. ET. Here’s what a success would actually change.
Advanced Micro Devices vs. Alphabet: What Do the Revenue Trajectories of These Artificial Intelligence Companies Tell Investors?
Alphabet’s revenue towers over AMD, but AMD’s growth rate tells a different story over the past eight quarters.
This Dirt Cheap Stock Reports Earnings July 30. Is It Finally Time to Buy Sirius XM?
After years of decline, the stock rallied by almost 50% in the first half of 2026.
Super Micro Just Reported $60 Billion of New Orders — Here’s Why Smart Investors Should Buy Dell Stock Now
Super Micro Computer recently published preliminary financial results for its fiscal fourth quarter.
Is It Too Late to Buy Bitcoin?
You missed Bitcoin’s peak several times already. Will you stick around to see the next one?
Are You a New Investor in 2026? Here’s 1 Costly Mistake to Avoid.
It’s often better to focus on minimizing blunders than to try and be exceptional.
Nvidia CEO Jensen Huang Just Posted For the First Time on X. Here’s What He Said.
Huang shared a joint letter about open-weight large language models.
Why Lockheed Martin Stock Keeps Going Up
Lockheed Martin had a terrific Q2 — and Wall Street noticed.
How Investing in This Altcoin Could Make You a Millionaire
This $1 altcoin might have 100x upside, but a lot has to go right for that to happen.
AI helps Stanford scientists discover “natural Ozempic” without the usual side effects
Stanford Medicine researchers have discovered a naturally occurring molecule that may suppress appetite and reduce body weight much like Ozempic, but without several of its common side effects. The molecule, called BRP, acts on a more targeted region o…
Scientists discover a compound that could supercharge aging muscle repair
A sulfur-based compound called LASSS appears to protect and supercharge a key protein involved in repairing damaged muscle. The discovery could eventually lead to new ways to slow muscle loss and preserve strength as people age.
A new antiviral could stop measles before an outbreak takes off
An experimental pill prevented a measles-like virus from spreading through the air or through close contact in ferrets. It worked when given shortly before or after exposure and also shortened illness and the period when infected animals remained conta…
The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients
Ozempic, Wegovy, and similar drugs may deliver excellent health value, but covering them for millions of eligible patients could overwhelm insurance budgets. Researchers say better long-term support is needed and warn that low-cost compounded versions …